"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

NCT00201994 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia
Water Intoxication
Inappropriate ADH Syndrome
Water-electrolyte Imbalance

Interventions

DRUG: Tolvaptan

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]